# Jeffrey A. Gilreath

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jeffrey-a-gilreath/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,159 |
| Field | Erythropoietin and Anemia Treatment |
| h-index | 13 |
| i10-index | 17 |
| Last Known Institution | University of Utah |
| OpenAlex ID | https://openalex.org/A5057070022 |
| ORCID iD | 0000-0002-4566-8448 |
| Works | 57 |

## Researcher papers

- [Diagnosis and treatment of cancer‐related anemia](https://scholariq.org/papers/diagnosis-and-treatment-of-cancer-related-anemia/)
- [Cancer- and Chemotherapy-Induced Anemia](https://scholariq.org/papers/cancer-and-chemotherapy-induced-anemia/)
- [How I treat cancer-associated anemia](https://scholariq.org/papers/how-i-treat-cancer-associated-anemia/)
- [Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists](https://scholariq.org/papers/thrombopoietin-receptor-agonists-tpo-ras-drug-class-considerations-for/)
- [Studying Cancer-Related Fatigue: Report of the NCCN Scientific Research Committee](https://scholariq.org/papers/studying-cancer-related-fatigue-report-of-the-nccn-scientific-research-committee/)
- [The Role of Intravenous Iron in the Treatment of Anemia Associated with Cancer and Chemotherapy](https://scholariq.org/papers/the-role-of-intravenous-iron-in-the-treatment-of-anemia-associated-with-cancer/)
- [Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma](https://scholariq.org/papers/comparison-of-acute-toxicity-and-mortality-after-two-different-dosing-regimens/)
- [On the safety of intravenous iron, evidence trumps conjecture](https://scholariq.org/papers/on-the-safety-of-intravenous-iron-evidence-trumps-conjecture/)
- [Proposed Algorithm for Managing Ibrutinib-Related Atrial Fibrillation.](https://scholariq.org/papers/proposed-algorithm-for-managing-ibrutinib-related-atrial-fibrillation/)
- [Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>)](https://scholariq.org/papers/efficacy-and-safety-of-ferric-carboxymaltose-infusion-in-reducing-anemia-in/)
- [Total Dose Iron Dextran Infusion in Cancer Patients: Is it SaFe<sup>2+</sup>?](https://scholariq.org/papers/total-dose-iron-dextran-infusion-in-cancer-patients-is-it-safe-sup-2-sup/)

## Researcher topics

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Iron Metabolism and Disorders](https://scholariq.org/topics/iron-metabolism-and-disorders/)
- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)
- [Tattoo and Body Piercing Complications](https://scholariq.org/topics/tattoo-and-body-piercing-complications/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

## Researcher university

- [University of Utah](https://scholariq.org/institutions/university-of-utah/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.